3 Things cover image

Looking back at 2025: Health developments that mattered most

3 Things

00:00

Available weight-loss drugs and market entry

Anonna Dutt outlines semaglutide and tirzepatide launches in India and their formulations and uptake.

Play episode from 04:15
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app